Drug development: more science, more education
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference8 articles.
1. Learning versus confirming in clinical drug development*
2. Features of this month's Journal
3. 3Food and Drug Administration. Challenge and Opportunity on the Critical Path to New Medical Products. Revised version. http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html (accessed 28 February, 2005).
4. Joining the DoTS: new approach to classifying adverse drug reactions
5. Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Direct Screening of Glycan Patterns from Human Sera: A Selective Glycoprotein Microarray Strategy;ACS Applied Bio Materials;2019-02-08
2. The Efficiency of India's Patent Layering Regime – Section 3(d) from Scientific Terminology to Patenting Implications;IIC - International Review of Intellectual Property and Competition Law;2015-09
3. Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK;BMJ Open;2013
4. Something New Every Day;Journal of Ambulatory Care Management;2008-01
5. The Value of a Drug;Journal of Ambulatory Care Management;2008-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3